In human CJD, CSF Nf-L is elevated before the RT-QuIC amplification assay can detect CSF prion seeding activity, and serum Nf-L is increased before clinical disease onset [27]. This evidence concerns the gene NEFL and Creutzfeldt Jacob disease.